Outcomes of the California ban on pharmaceutical lindane: Clinical and ecologic impacts

Environmental Health Perspectives

Volumn 116, Issue 3, 2008, Pages 297-302

  Humphreys, Elizabeth H ^a,d   Janssen, Sarah ^b,c   Heil, Ann ^a   Hiatt, Patricia ^a   Solomon, Gina ^a,b,c   Miller, Mark D ^a,c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATURAL RESOURCES DEFENSE COUNCIL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Sanitation Districts of Los Angeles County   (United States)

^e CALIFORNIA ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Contamination; Head lice; Lindane; Persistent organic pollutant; Pharmaceutical; Physician survey; Scabies; Unintentional ingestions; Wastewater

Indexed keywords

LINDANE;

ARTICLE; DRUG EXPOSURE; DRUG LEGISLATION; EFFLUENT; ENVIRONMENTAL MONITORING; OUTCOMES RESEARCH; PEDIATRICIAN; PEDICULOSIS CAPITIS; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCABIES; UNITED STATES; WASTE WATER; WASTE WATER TREATMENT PLANT; WATER CONTAMINATION; WATER QUALITY;

ANTIPARASITIC AGENTS; CALIFORNIA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; HUMANS; INSECTICIDES; LEGISLATION, DRUG; LICE INFESTATIONS; LINDANE; SEWAGE; WATER POLLUTANTS, CHEMICAL;

PEDICULUS HUMANUS;

EID: 40849092643     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10668     Document Type: Article

References (47)

1. Agency for Toxic Substances and Disease Registry. 2005. Toxicological Profile for Hexachlorocyclohexane. Atlanta, GA:Agency for Toxic Substances and Disease Registry. Available: http://www.atsdr.cdc.gov/ toxprofiles/tp43.html [accessed 6 March 2007].
2. Asch DA, Jedrziewski MK, Christakis NA. 1997. Response rates to mail surveys published in medical journals. J Clin Epidemiol 50(10):1129-1136.
3. California Department of Health Services. 2007. Medi-Cal Drug Utilization Data. Available: http://www.dhs.ca.gov/mcs/mcpd/mbb/ contracting/files/defaulhtm [accessed 21 October 2007].
4. CDC. 2005a. Hexachlorocyclohexane (CAS No 608-73-1). In: Third National Report on Human Exposure to Environmental Chemicals, Atlanta, GA:Centers for Disease Control and Prevention, 313-317 Available: http:/www.cdc.gov/ exposurereport/pdf/thirdreport.pdf [accessed 10 January 2007].
5. CDC. 2005b, Unintentional topical lindane ingestions - United States, 1998-2003. MMWR Morb Mortal Wkly Rep 54(21):533-535.
6. CEC (Commission for Environmental Cooperation). 2006. Northern American Regional Action Plan (NARAP) on Lindane and Other Hexachlorocyclohexane (HCH) Isomers. Available: http://www.cec.org/files/PDF/POLLUTANTS/ LindaneNARAP-Nov06_en.pdf [accessed 1 February 2007].
7. Chambers DB, Leiker TJ. 2006. A Reconnaissance for Emerging Contaminants in the South Branch Potomac River, Cacapon River, and Williams River Basins, West Virginia, April-October 2004. USGS Open-File Report 2000-1393. Available http://pubs.usgs.gov/of/2006/1393 [accessed 6 March 2007].
8. CSDLAC. 2000. Pretreatment Program Annual Report. Los Angeles:County Sanitation Districts of Los Angeles County.
9. CSDLAC. 2001. Lindane Usage Reduction Pilot Project, 1998 Pollution Prevention Leadership Grant Program, Final Report. Los Angeles:County Sanitation Districts of Los Angeles County.
10. Dodd CS. 2001. Interventions for Treating Headlice. Cochrane Database Syst Rev (3):CD001165.
11. Downs AM, 2004. Managing head lice in an era of increasing resistance to insecticides. Am J Clin Dermatol 5(3):169-177.
12. FDA JFood and Drug Administration). 2003a. Lindane Lotion, USP, 1% Prescribing Information, Available: http://www.fda.gov/cder/foi/label/ 2003/006309lotionlbl.pdf [accessed 6 March 2007].
13. FDA (Food and Drug Administration). 2003b. Lindane Shampoo, USP, 1%. Available: http://www.fda.gov/cder/foi/label/2003/006309shampoolbl.pdf [accessed 6 March 2007].
14. FDA (Food and Drug Administration), 2003c. Public Health Advisory: Safety of Topical Lindane Products for the Treatment of Scabies and Head Lice. FDA/Center for Drug Evaluation and Research. Available: http://www.fda.gov/cder/drug/infopage/lindane/lindanePHA.htm [accessed 1 February 2007].
15. Fent K, Weston AA, Caminada D. 2006 Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76:122-159.
16. Frankowski BL, Weiner LB. Committee on School Health and Committee on Infectious Diseases. 2002. Head Lice. Pediatrics 110(3):638-643.
17. Goates BM, Atkin JS, Wilding KG, Birch KG, Cottam MR, Bush SE, et al. 2006. An effective nonchemical treatment for head lice: a lot of hot air. Pediatrics 118(5):1962-1970.
18. Hemminger P. 2005. Damming the flow of drugs into drinking water. Environ Health Perspect 113:A678-A681.
19. Heukelbach J, Feldmeier H. 2006. Scabies. Lancet 367(9524): 1767-1774.
20. Hill N, Moor G, Butlin A, Preston S, Williamson MS, Bass C. 2005. Single blind, randomized comparative study of the Bug Buster kit and the over the counter pediculocide treatments against head lice in the United Kingdom. BMJ 331(7513):384-387.
21. International Agency for Research on Cancer. 1998. Summaries and Evaluations: Hexachlorocyclohexanes (Group 2B). Available: http://www.inchem.org/documents/iarc/suppl7/hexachlorocyclohexanes.html [accessed 13 March 2007].
22. International POPs Elimination Network. 2007. Submission to the POPs Review Committee of the Stockholm Convention on persistent Organic Pollutants. Available: http://www.pops.int/documents/meetings/poprc/ prepdocs/annexFsubmissions/Lindane%201PEN.pdf [accessed 26 February 2007].
23. Jensen A, Slorach SA. 1991. Chemical Contaminants in Human Milk. Boca Raton, FL:CRC Press Inc.
24. Jones KN, English JC III. 2003. Review of common therapeutic options in the United States for the treatment of Pediculosis capitis. Clin Infect Dis 36:1355-1361.
25. Karthikeyan K. 2005. Treatment of scabies: newer perspectives. Postgrad Med J 81:7-11.
26. Ko CJ, Elston DM. 2004. Pediculosis. J Am Acad Dermatol 50:1-12.
27. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SO, Barber LB, et al. 2002. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ Sci Technol 36(6):1202-1211.
28. Konishi YK, Kuwabara K, Hori S. 2001. Continuous surveillance of organochlorine compounds in breastmilk from 1972 to 1998 in Osaka, Japan. Arch Environ Contam Toxicol 40(4):571-578.
29. McMahon SR, Iwamoto M, Massoudi MS, Yusuf HR, Stevenson JM, David F, et al. 2003. Comparison of e-mail, fax, and postal surveys of pediatricians. Pediatrics 111(4 Pt 1):e299-303.
30. Meinking TL. 2004. Clinical update on resistance and treatment of Pediculosis capitis. Am J Manag Care 10:S264-268.
31. Meinking TL, Serrano L, Hard B, Entzel P, Lemard G, Rivera E, et al. 2002. Comparative in vitro pediculocidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol 38(2):220-224.
32. Pardio VT, Waliszewski KN, Landin LA, Bautista RG. 2003. Organochlorine pesticide residues in cow's milk from a tropical region of Mexico. Food Addit Contam 20(3):259-269.
33. Pearlman DL. 2004. A simple treatment for head lice: dry-on, suffocation-based pediculocide. Pediatrics 114(3):e275-279.
34. Schade G, Heinzow B. 1998. Organochlorine pesticides and polychlorinated biphenyls in human milk of mothers living in northern Germany: current extent of contamination, time trend from 1986 to 1997 and factors that influence the levels of contamination. Sci Total Environ 215(1-2):31-39.
35. State of California. 2000. An Act to Add Section 111246 to the Health and Safety Code, relating to environmental health. Assembly Bill No. 2318.
36. The Medical Letter. 2005. Drugs for head lice. Med Lett Drugs Ther 47(1215-1216):68-70.
37. Thomson Healthcare. 2007. Poisindex ® System. Micromedex Healthcare Series Vol 131. Greenwood Village, CO:Thomson Healthcare.
38. Thomson Micromedex. 2006. Lindane topical. In: Volume 1: Drug information for the Healthcare Professional. 26th ed. Greenwood Village, CO:Thomson Micromedex, 1940-1943.
39. U.S. EPA (U.S. Environmental Protection Agency). 2000. Water quality standards: establishment of numeric criteria for priority toxic pollutants for the State of California; final rule. Fed Reg 65:31681-31719. Available: http://www.epa.gov/EPA-WATER/2000/May/Day-18/ w11106.htm [accessed 29 March 2007].
40. U.S. EPA. 2002. Estimated Concentrations of Lindane in Surface Water Used as a Source of Drinking Water from Use and Disposal of Shampoo and Lotion into Household Wastewater. DP Code D282004. Washington, DC:U.S. Environmental Protection Agency.
41. U.S. EPA (U.S. Environmental Protection Agency). 2006. Lindane, Cancellation Order. Fed Reg 71:74905-74907. Available: http://www.epa.gov/fedrgstr/EPA-PEST/2006/December/Day-13/p21101.htm [accessed 1 February 2007].
42. U.S. EPA (U.S. Environmental Protection Agency). 2007. Submission by the United States of America to the Secretariat of the Stockholm Convention for socioeconomic information for Lindane, compiled by Janice Jensen, Washington, DC:Office of Pesticide Programs. Annex F Questionnaire. Available: http://www.pops.int/documents/meetings/poprc/prepdocs/ annexFsubmissions/Lindane%20USA.doc [accessed 26 February 2007].
43. Verispan Inc. 2007. Vector One® National (VONA) Report. Yardley, PA:Verispan Inc.
44. Vijgen J. 2006. The Legacy of Lindane HCH Isomer Production; Main Report; A Global Overview of Residue Management, Formulation and Disposal. International HCH & Pesticides Association. Available: www.milieukontakt.nl/file.php?table_name=activity&id= 311&field_name=documentation_1_file [accessed 1 February 2007].
45. Waliszewski SM, Villalobos-Pietrini R, Gomez-Arroyo S, Infanzon RM. 2003. Persistent organochlorine pesticides in Mexican butter. Food Addit Contam 20(4):361-367.
46. Walker GJA, Johnstone PW. 2000. Interventions for treating scabies. Cochrane Database Syst Rev (3):CD000320.
47. West DP. 2004. Head lice treatment costs and the impact on managed care. Am J Manag Care 10(9):S277-282.